

%201.webp)


%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)


%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

Sri Lanka is implementing a national pharmaceutical track and trace framework under the National Medicines Regulatory Authority (NMRA). The system is designed to improve supply chain transparency, strengthen recall management, and prevent falsified medicines from entering the legal distribution network.
The national framework requires standardized product identification and digital reporting of medicine movement across the pharmaceutical supply chain. The system is based on GS1 standards and aims to provide end to end visibility of medicines from manufacturer or importer to healthcare institutions and pharmacies.
Manufacturers, importers, distributors, and healthcare institutions are expected to adopt standardized barcoding and electronic reporting to support the national traceability system.
Pharmaceutical products supplied to Sri Lanka must support standardized barcode identification aligned with GS1 standards.
Each sellable pack is expected to carry a machine readable barcode containing:
Barcodes are typically implemented using a GS1 DataMatrix or GS1 128 depending on packaging level and supply chain design.
Human readable product information printed on packaging must match the encoded barcode data.
Supply chain locations may use Global Location Numbers (GLN) to uniquely identify manufacturers, importers, distributors, warehouses, hospitals, and pharmacies.
2015 – National Medicines Regulatory Authority established to strengthen medicine regulation and supply chain oversight.
2018 – Initial initiatives launched to digitize medicine registration and strengthen pharmaceutical supply chain monitoring.
2020 – NMRA begins developing a national pharmaceutical track and trace framework.
2022 onward – Implementation activities continue to expand electronic reporting and traceability capabilities across supply chain participants.
Sri Lanka is implementing a centralized pharmaceutical traceability system under the National Medicines Regulatory Authority.
The system supports digital reporting of pharmaceutical product movement across the supply chain and enables regulators to monitor distribution, investigate suspicious products, and manage product recalls.
Supply chain participants submit product and transaction data through electronic reporting mechanisms integrated with the national traceability platform.
The system is designed to support interoperability between manufacturer systems, importer systems, distribution systems, and regulatory platforms.
The Sri Lankan framework supports packaging hierarchy identification to enable tracking of logistics units through the supply chain.
Logistics units such as cases or pallets may be identified using SSCC identifiers to support distribution visibility and warehouse operations.
While pack level identification is essential for traceability, aggregation hierarchies may be implemented by manufacturers and distributors to improve supply chain efficiency and reporting.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.